From Medscape Neurology

Coverage from the

American Academy of Neurology (AAN) 2023 Annual Meeting

April 22 - 27, 2023; Boston, Massachusetts

April 22 - 27, 2023 Boston, Massachusetts

AAN 2023 Direct Comparison of 25 Migraine Meds Reveals Top Options A large, real-world data analysis of 3 million migraine attacks shows triptans, ergots, and antiemetics are the most effective classes of medications.
Medscape Medical News, May 2, 2023
AAN 2023 Noninvasive Test in Midlife Flags Late-Onset Epilepsy Risk Some 30% of late-onset epilepsy cases have no known cause. A simple neurocognitive test and an MRI given in midlife could identify those at highest risk.
Medscape Medical News, April 25, 2023
AAN 2023 Ablation for Atrial Fibrillation May Protect the Aging Brain Restoring normal heart rhythm via catheter ablation may improve long-term cognitive outcomes in older adults with atrial fibrillation.
Medscape Medical News, April 24, 2023

Conference News

AAN 2023 Nonmedical Cannabis Use Common in Patients With Epilepsy
Medscape Medical News, May 9, 2023
AAN 2023 Stroke Scale Cutoff Might Not Be Ideal Guide
MDedge News, May 5, 2023
AAN 2023 Teriflunomide Delays MS Symptoms in RIS
MDedge News, May 5, 2023
AAN 2023 Novel Levodopa Delivery System Promises Continuous Dosing
MDedge News, May 4, 2023
AAN 2023 Stroke Prevalence Stable in US Over Past 20 Years
Medscape Medical News, May 3, 2023
AAN 2023 US Incidence, Prevalence of Myasthenia Gravis Rising
Medscape Medical News, May 2, 2023
AAN 2023 Direct Comparison of 25 Migraine Meds Reveals Top Options
Medscape Medical News, May 2, 2023
AAN 2023 Oral Anti-Amyloid Shows Disease-Modifying Potential
Medscape Medical News, April 28, 2023
AAN 2023 Donanemab Bests Aducanumab in Head-to-Head AD Trial
Medscape Medical News, April 27, 2023
AAN 2023 Machine Learning Predicts Primary Progressive MS Progression
MDedge News, April 27, 2023
AAN 2023 Therapy to Reverse Muscle Dystrophies Shows Promise
MDedge News, April 27, 2023
AAN 2023 Atogepant Prevents Episodic Migraine in Some Cases
MDedge News, April 27, 2023
AAN 2023 Novel PD Drug Tops Pramipexole ER With Fewer Side Effects
Medscape Medical News, April 26, 2023

AAN 2023 Novel Continuous Infusion System Promising for Parkinson's
MDedge News, April 26, 2023
AAN 2023 Noninvasive Test in Midlife Flags Late-Onset Epilepsy Risk
Medscape Medical News, April 25, 2023
AAN 2023 Novel Agent Offers Hope for Hereditary ATTR Polyneuropathy
Medscape Medical News, April 25, 2023
AAN 2023 Ablation for Atrial Fibrillation May Protect the Aging Brain
Medscape Medical News, April 24, 2023
AAN 2023 Novel Neural Cell Therapy a Cure for Focal Epilepsy?
Medscape Medical News, April 21, 2023
AAN 2023 Spinal Cord Stimulation May Help Diabetic Neuropathy
MDedge News, April 14, 2023
AAN 2023 Urban Green, Blue Spaces Linked to Less Psychological Distress
MDedge News, April 12, 2023
AAN 2023 Mississippi–Ohio River Valley Linked to Higher Risk of Parkinson's
MDedge News, April 12, 2023
AAN 2023 Cardiovascular Measures Linked to Reduced Dementia Risk in Women
MDedge News, April 12, 2023
AAN 2023 Even Mild COVID Is Hard on the Brain
Medscape Medical News, March 6, 2023
AAN 2023 Black People Less Likely to Receive Dementia Meds
Medscape Medical News, March 3, 2023
AAN 2023 Aerobic, Breathing Exercises Tied to Faster Concussion Recovery
Medscape Medical News, March 3, 2023

Medscape Neurology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Top 5 Movement Disorders Highlights From AAN 2023
Kathrin LaFaver, MD; Indu Subramanian, MD
What to Expect in the New Concussion Guidelines
Andrew N. Wilner, MD; Shae Datta, MD
Virtual Reality in ASD: From Second Life to Real Life
Andrew N. Wilner, MD; Dana I. Allison
Posttraumatic Headache: What Works, What Doesn't
Andrew N. Wilner, MD; Nina Riggins, MD, PhD

Popular News from AAN 2022

Experimental Drug May Boost Executive Function in Alzheimer's A small, phase 2 trial found improved executive functioning in patients with Alzheimer's and mild cognitive impairment and mild dementia.
Medscape Medical News, Mar 31, 2022
More Evidence COVID 'Brain Fog' Is Biologically Based Patients with 'brain fog' during acute COVID-19 had the highest levels of inflammatory markers, offering additional evidence of a neurological basis for post-acute sequelae of SARS-CoV-2 infection.
Medscape Medical News, Apr 01, 2022
Can Caring for a Pet Protect the Aging Brain? Long-term pet ownership may help mitigate cognitive decline in older adults, perhaps from the stress-buffering effects and increased physical activity, new research suggests.
Medscape Medical News, Feb 23, 2022

Previous Coverage

Related Resources